Lipocine (LPCN) Institutional Ownership $3.28 -0.03 (-0.91%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$3.42 +0.14 (+4.39%) As of 03/28/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Lipocine (NASDAQ:LPCN)CurrentInstitutional OwnershipPercentage9.11%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$151.56KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.98K Get LPCN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lipocine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LPCN Institutional Buying and Selling by Quarter Remove Ads Lipocine Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Renaissance Technologies LLC36,032$176K0.0%-10.7%0.673% 2/12/2025 Geode Capital Management LLC57,464$280K0.0%+6.0%1.074% 8/9/2024 Renaissance Technologies LLC25,697$212K0.0%+21.8%0.480% 8/9/2024 Dimensional Fund Advisors LP11,870$98K0.0%N/A0.222% 1/29/2024 Wealth Effects LLC14,639$41K0.0%-22.0%0.275% 10/16/2023 Wealth Effects LLC18,761$56K0.0%-35.9%0.353% 7/18/2023 Wealth Effects LLC29,273$148K0.1%-96.1%0.563% 6/5/2023 EP Wealth Advisors LLC66,983$13.40M0.2%N/A1.288% 5/4/2023 Wealth Effects LLC756,674$241K0.1%-35.8%0.855% 2/13/2023 Wealthspan Partners LLC73,950$29K0.0%N/A0.084% Get the Latest News and Ratings for LPCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lipocine and its competitors with MarketBeat's FREE daily newsletter. 2/2/2023 Wealth Effects LLC1,178,834$469K0.3%-3.0%1.332% 2/2/2023 Bailard Inc.82,957$32K0.0%N/A0.094% 11/7/2022 Virtu Financial LLC93,411$42K0.0%N/A0.106% 8/3/2022 Carson Advisory Inc.52,000$42K0.0%N/A0.059% 7/27/2022 Bailard Inc.74,400$60K0.0%N/A0.084% 7/22/2022 Aaron Wealth Advisors LLC145,045$116K0.0%+23.4%0.164% 5/13/2022 EAM Investors LLC657,804$901K0.2%N/A0.743% 5/10/2022 Aaron Wealth Advisors LLC117,552$85.81M1.2%N/A0.133% 4/26/2022 Kestra Advisory Services LLC307,300$421K0.0%+27.9%0.347% 2/14/2022 GSA Capital Partners LLP440,432$437K0.1%+39.7%0.499% 2/9/2022 Wealth Effects LLC1,489,434$1.48M0.6%N/A1.687% 11/15/2021 GSA Capital Partners LLP315,308$344K0.0%+122.8%0.357% 11/10/2021 Mercer Global Advisors Inc. ADV313,111$341K0.0%+6.8%0.355% 11/9/2021 Barclays PLC24,075$26K0.0%+243.3%0.027% 10/19/2021 Kestra Advisory Services LLC249,418$272K0.0%+256.3%0.282% 8/16/2021 State Street Corp304,617$426K0.0%+2,356.6%0.345% 8/13/2021 Northern Trust Corp173,117$242K0.0%+16.8%0.196% 8/13/2021 LPL Financial LLC62,750$88K0.0%+46.8%0.071% 8/13/2021 Geode Capital Management LLC760,586$1.06M0.0%+26.0%0.861% 8/13/2021 Vanguard Group Inc.3,815,348$5.34M0.0%+6.4%4.321% 8/12/2021 XTX Topco Ltd20,706$29K0.0%-30.8%0.023% 8/11/2021 Bank of New York Mellon Corp110,204$154K0.0%+99.6%0.125% 8/11/2021BlackRock Inc.1,582,415$2.22M0.0%-2.5%1.792% 8/10/2021 Mercer Global Advisors Inc. ADV293,111$410K0.0%+38.8%0.332% 8/10/2021 Principal Financial Group Inc.20,382$29K0.0%N/A0.023% 8/5/2021 GSA Capital Partners LLP141,521$198K0.0%+12.3%0.160% 5/19/2021 Virtu Financial LLC191,387$289K0.0%-8.0%0.217% 5/19/2021 Squarepoint Ops LLC84,001$127K0.0%+515.5%0.095% 5/18/2021 Cubist Systematic Strategies LLC55,200$83K0.0%N/A0.063% 5/18/2021 Jane Street Group LLC29,060$44K0.0%N/A0.033% $2 Trillion Disappears Because of Fed's Secretive New Move (Ad)$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.Click here to see his new research now.5/17/2021 Price T Rowe Associates Inc. MD89,264$135K0.0%N/A0.101% 5/17/2021 Ameriprise Financial Inc.702,000$1.06M0.0%-4.2%0.795% 5/14/2021 MML Investors Services LLC41,000$62K0.0%N/A0.046% 5/14/2021 XTX Topco Ltd29,929$45K0.0%N/A0.034% 5/13/2021 Barclays PLC21,594$33K0.0%N/A0.024% 5/12/2021 Northern Trust Corp148,222$224K0.0%+19.3%0.168% 5/12/2021 Geode Capital Management LLC603,713$911K0.0%+33.9%0.684% 5/11/2021 Mercer Global Advisors Inc. ADV211,210$319K0.0%-27.5%0.239% 5/10/2021 GSA Capital Partners LLP125,993$190K0.0%-32.3%0.143% 2/24/2021 Virtu Financial LLC207,996$283K0.0%N/A0.253% 2/11/2021 Northern Trust Corp124,210$169K0.0%+40.4%0.151% 2/9/2021 Bank of New York Mellon Corp60,886$83K0.0%N/A0.074% 2/5/2021BlackRock Inc.1,618,913$2.20M0.0%+0.5%1.972% (Data available from 1/1/2016 forward)Remove Ads LPCN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LPCN shares? During the previous two years, the following institutional investors and hedge funds held shares of Lipocine shares: EP Wealth Advisors LLC ($13.40M), Geode Capital Management LLC ($280K), Renaissance Technologies LLC ($176K), and Dimensional Fund Advisors LP ($98K), Wealth Effects LLC ($41K).Learn more on LPCN's institutional investors. What percentage of Lipocine stock is owned by institutional investors? 9.11% of Lipocine stock is owned by institutional investors. Learn more on LPCN's institutional investor holdings. Which institutional investors have been buying Lipocine stock? The following institutional investors have purchased Lipocine stock in the last 24 months: EP Wealth Advisors LLC ($66.98K), Dimensional Fund Advisors LP ($11.87K), Renaissance Technologies LLC ($4.60K), and Geode Capital Management LLC ($3.25K). How much institutional buying is happening at Lipocine? Institutional investors have bought a total of 86,701 shares in the last 24 months. This purchase volume represents approximately $513.79K in transactions. Which Lipocine major shareholders have been selling company stock? The following institutional investors have sold Lipocine stock in the last 24 months: Wealth Effects LLC ($1.16M), and Renaissance Technologies LLC ($4.30K). How much institutional selling is happening at Lipocine? Institutional investors have sold a total of 1,168,495 shares in the last 24 months. This volume of shares sold represents approximately $6.01M in transactions. Related Companies JSPR Major Shareholders CLSD Major Shareholders IGMS Major Shareholders ABOS Major Shareholders PYXS Major Shareholders AVTE Major Shareholders GNTA Major Shareholders MNOV Major Shareholders CRBP Major Shareholders CLLS Major Shareholders This page (NASDAQ:LPCN) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipocine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipocine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LPCN Stock Free LPCN Stock Alerts